The Weekly Roundup: March 3-7

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Celebrating Women’s History Month with Mindy Haws, MD, and the LIMITLESS Initiative

“It's so exciting to see all these incredible female talents behind me. I want to give back and I want to help them climb on my shoulders and go higher,” Haws said.

Edgar Charles, MD, on Long-term Deucravacitinib Psoriasis Data

Dermatology Times spoke with Edgar Charles, MD, vice president and senior global program lead, Early/Late Development Immunology, Bristol Myers Squibb, for insight into new 5-year data from the POETYK PSO long-term extension (LTE) trial.

Apogee Therapeutics' APG990 Demonstrates Extended Half-Life and Favorable Tolerability in Interim Phase 1 Data

APG990 showed a 60-day half-life and favorable safety, supporting potential 3-6 month maintenance dosing for atopic dermatitis.

Acne and TikTok: What Do Dermatologists Need to Know?

A new qualitative analysis revealed which type of content on acne is trending on the social media platform and how clinicians should respond.

Q&A: Thomas Casale, MD, Discusses Abstract on Dupilumab and Significant Itch, Hive Reduction in Chronic Spontaneous Urticaria

Phase 3 trial results presented at AAAAI/WAO 2025 highlight dupilumab's efficacy in reducing itch severity and urticaria activity in CSU patients.

The Environmental Cost of Conferences

Single-use packaging and excess sample distribution contribute to environmental harm, necessitating a shift in industry practices.

Recognizing the Achievements of Women in Dermatology

Celebrate Women’s History Month 2025 with insights from leading female dermatologists and expert coverage from the AAD Annual Meeting in Orlando.

Antimicrobial and Steroid Combination Therapy Restores Skin’s Bacterial Microbiome in Patients with AD

When compared to corticosteroids alone, the combination therapy reduced disease severity and improved the skin barrier.

Understanding and Treating Pediatric AD Inside and Out

Experts discussed pediatric atopic dermatitis, treatment innovations, disease burden, and the latest topical and systemic therapies in a DermView video series.

Clinical Trial Supports Emollient “Plus” for Improving AD

Research suggests that rebalancing the skin microbiome with pre-, post-, and probiotics may improve AD symptoms.

“The Undetectable Era”: How Patients Are Shifting Towards More Natural-Looking Results at the Clinic

In a conversation with Kristy Hamilton, MD, FACS, she spoke about the recent aesthetic trend and how clinicians can align with new patient expectations.

SLIDESHOW: 2025 Pre-AAD Meetings

Both the Skin of Color Society as well as the Society for Pediatric Dermatology will meet on March 6 to share research, clinical insights, and pearls for attendees to keep in mind as new data comes to the forefront.

New Survey By LEO Pharma and Ipsos Highlights Diagnostic, Treatment Gaps in Chronic Hand Eczema

A new survey reveals widespread misunderstanding and lack of effective treatments in chronic hand eczema.

Celebrating Women’s History Month by Honoring Women in Dermatology: A Sit-Down Interview With WDS Legacy Awardee Dr Adelaide Hebert

Dematology Times' Editor in Chief interviews Adelaide Hebert, MD, who will be honored at the AAD 2025 Legacy Celebration for her impact on pediatric dermatology.

Takeda Targets Clinical Disparities in Psoriasis Research

Psoriasis trials are among the least diverse within dermatology, with participants predominantly being white men.

LaShell Robinson on Takeda’s Initiative to Improve Research Diversity

Robinson shared insights into how the company is working to fight clinical research disparities.

ICYMI: Quoin Files New Rapamycin Patent Applications for Rare Disease Treatment

The novel formulations will harness Quoin’s Invisicare technology to treat microcystic lymphatic malformations, venous malformations, and angiofibromas.

Experts Share Tips for Optimizing Topical vs Systemic Therapies for AD

Experts discussed personalized approaches to atopic dermatitis, from steroid-sparing topicals to biologics, highlighting rapid relief and long-term management strategies.

Polyherbal Lip Hydrant Healed Chapped and Rough Lips, Compared to Petroleum Gel

The novel formulation improved the appearance of dry and chapped lips after 28 days of use.

Q&A: Jonathan Bernstein, MD, FAAAAI, Discusses Advances in Chronic Spontaneous Urticaria Treatments and AAAAI Data

At AAAAI/WAO 2025, Bernstein explored new findings on rilzabrutinib and dupilumab in CSU, highlighting treatment gaps and future therapies.

Tailored Laser and Light-Based Therapies for Acne, Skin of Color, and Inflammatory Conditions

Experts discussed laser and light-based therapies for acne, rosacea, hyperpigmentation, and inflammatory skin diseases.

Pipeline Updates on the Horizon From Arcutis Biotherapeutics

Patrick Burnett, MD, PhD, shares key updates expected in 2025 for therapeutics treating atopic dermatitis, alopecia areata, and more.

Previewing Editorial Advisory Board Member Sessions at AAD 2025

Among the many sessions to be held at the American Academy of Dermatology Annual Meeting in Orlando, Florida, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Vitiligo in Clinical Practice: Expert Insights on Diagnosis, Comorbidities, and Treatment

Serota and other field experts discussed best practices as well as new therapeutics.

Journey Medical Publishes Full Phase 3 Trial Results for DFD-29

The findings of the MVOR-1 and MVOR-2 studies are published in JAMA Dermatology, supporting the rosacea drug’s recent FDA approval.

All of Us: An Analysis of the Current Vitiligo Treatment Landscape in America

The analyzed dataset included over 200,000 patients with vitiligo to find trends in diagnosis, treatment, and more.

Previewing the 2025 AAD Annual Meeting: What to Expect and Tips from the Experts

Read more on how to navigate all the opportunities at this year’s AAD meeting, which starts today in Orlando, Florida.

Adewole Adamson, MD, MPP: Getting Ready to Tackle Dermatology's Key Challenges Issues at AAD 2025

Adamson highlights key topics to expect at the AAD Annual Meeting, emphasizing the importance of tackling controversial issues and fostering collaboration.

Zoe Diana Draelos, MD: Gearing Up for AAD

Ahead of the annual meeting, Dermatology Times spoke with Draelos about why she looks forward to the meeting each year.

Adam Friedman, MD, FAAD: Expert Insights and Advice on Navigating AAD

Along with his session insights on diet and chronic spontaneous urticaria, Friedman shares tips for navigating the largest dermatology conference in the US.